Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3729-3736

  Shnyra, Alexander ^a   Brewington, Ryan ^a   Alipio, Arlene ^a,b   Amura, Claudia ^a   Morrison, David C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b United Laboratories   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; FEMALE; GENE EXPRESSION REGULATION; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; FEMALE; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; NEUTRALIZATION TESTS; NITRIC OXIDE; PHENOTYPE; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032522648     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417.
2. Akira, S., and T. Kishimoto. 1992. Mechanisms of soluble mediators. Curr. Opin. Immunol. 4:307.
3. Freudenberg, M. A., Y. Yaegashi, P. Nielsen, Y. Kumazawa, M. Aguet, and C. Galanos. 1996. Mechanism of sensitization to endotoxin by bacteria. In The Immune Consequences of Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches. E. Faist, A. E. Baue, and F. W. Schildberg, eds. Pabst Science Publishers, Lengerich, pp. 804-815.
4. Johnston, C. A., and S. E. Greisman. 1985. Mechanism of endotoxin tolerance. In Handbook of Endotoxin, Vol. 2. L. B. Hinshaw, ed. Elsevier, Amsterdam, New York, and Oxford, pp. 359-391.
5. Beeson, P. B. 1947. Tolerance to bacterial pyrogens. I. Factors influencing its development. J. Exp. Med. 86:29.
6. Haslberger, A., T. Sayers, H. Reiter, J. Chung, and E. Schutze. 1988. Reduced release of TNF and PCA from macrophages of tolerant mice. Circ. Shock 26:185.
7. Freudenberg, M. A., and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pre-treatment with LPS is mediated by macrophages. Infect. Immun. 56:1352.
8. Mathison, J. C., G. D. Virca, N. Wolfson, P. S. Tobias, K. Glaser, and R. J. Ulevitch. 1990. Adaptation to bacterial lipopolysaccharide (LPS) controls LPS-induced tumor necrosis factor production in rabbit macrophages. J. Clin. Invest. 85:1108.
9. Henricson, B. E., W. R. Benjamin, and S. N. Vogel. 1990. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58:2429.
10. Erroi, A., G. Fantuzzi, M. Mengozzi, M. Sironi, S. F. Orencole, B. D. Clark, C. A. Dinarello, A. Isetta, P. Gnocchi, M. Giovarelli, and P. Ghezzi. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 61:4356.
11. Virca, G. D., S. Y. Kim, K. B. Glaser, and R. J. Ulevitch. 1989. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J. Biol. Chem. 264:21951.
12. Fahmi, H., and R. Chaby. 1993. Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites. Cell. Immunol. 150:219.
13. Cavaillon, J. M., C. Pitton, and C. Fitting. 1994. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J. Endotoxin Res. 1:21.
14. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on TNF-α and nitric oxide production. J. Exp. Med. 177:511.
15. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukocyte Biol. 54:444.
16. Hirohashi, N., and D. C. Morrison. 1996. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 64:1011.
17. Stuehr, D. J., and Nathan C. F. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543.
18. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
19. Kamogawa, Y., L. E. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 75:985.
20. + T cells. Annu. Rev. Immunol. 12:635.
21. Bradley, L. M., K. Yoshimoto, and S. L. Swain. 1995. The cytokines IL-4, IFN-γ, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J. Immunol. 155:1713.
22. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
23. Chehimi, J., and G. Trinchieri. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149.
24. Maruo, S., K. Toyo-oka, M. Oh-hora, X. G. Tai, H. Iwata, H. Takenaka, S. Yamada, S. Ono, T. Hamaoka, M. Kobayashi, M. Wysocka, G. Trinchieri, and H. Fujiwara. 1996. IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. J. Immunol. 156:1748.
25. + T cells occurs through macrophage production of IL-12. Science 260:547.
26. Nakamura, T., R. K. Lee, S. Y. Nam, E. R. Podack, K. Bottomly, and R. A. Flavell. 1997. Role of IL-4 and IFN-γ in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol. 158:2648.
27. Sieling, P. A., J. S. Abrams, M. Yamamura, P. Salgame, B. R. Bloom, T. H. Rea, and R. L. Modlin. 1993. Immunosuppressive role of IL-10 and IL-4 in human infection. J. Immunol. 150:5501.
28. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
29. Fultz, M. J., S. A. Barber, C. W. Dieffenbach, and S. N. Vogel. 1993. Induction of IFN-γ in macrophages by lipopolysaccharide. Int. Immunol. 5:1383.
30. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
31. + T cells to enhance priming for interferon-γ production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
32. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-7 production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
33. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of Interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
34. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
35. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
36. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.